R&D

Hong Kong Researchers Explore TES for Depression and Alzheimer’s Treatment

Company

CASI Pharmaceuticals Invests in Precision Immune Therapeutics for CID-103 Development

Company

Sinopharm in Talks to Acquire BBI Life Sciences in USD 1B+ Deal

CompanyLegal / IP

Acer Therapeutics and Relief Therapeutics Awarded China Patent for ACER-001

CompanyDeals

Bangbang Robot Raises USD 14.9M in Series B to Expand Mobility Tech

CompanyDrug

OBI Pharma Halts OBI 888 Trial Over Manufacturing Costs, Shifts Focus to Globo H ADC

CompanyDrug

Hengrui Medicine’s SHR8554 Accepted for NMPA Review in Postoperative Pain

R&D

Insilico Medicine Identifies Novel ALS Therapeutic Targets via AI Platform PandaOmics

CompanyDrug

CSPC Pharmaceutical’s JMT103 Anti-RANKL Antibody Prioritized for CDE Review

CompanyDrug

Gan & Lee Pharmaceuticals’ GZR4 Ultra-Long-Acting Insulin Receives Clinical Trial Approval

CompanyDeals

Aden Secures USD 29.8M Series B+ Funding to Expand DRG/DIP Solutions

Policy / Regulatory

NMPA Issues New Vaccine Manufacturing and Distribution Rules